Related Experiment Videos

Opioids activate G proteins in REM sleep-related brain stem nuclei of rat

M L Capece1, H A Baghdoyan, R Lydic

  • 1Department of Anesthesia, Pennsylvania State University College of Medicine, Hershey 17033, USA.

Neuroreport
|November 6, 1998
PubMed

Insights

Opioid drugs inhibit REM sleep by activating G proteins in specific brainstem areas. This study shows that DAMGO, a mu opioid agonist, activates these G proteins in key REM sleep regulatory nuclei.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Mu opioid receptors are implicated in the inhibition of rapid eye movement (REM) sleep.
  • These receptors are known to be coupled to guanine nucleotide binding (G) proteins.

Purpose of the Study:

  • To investigate whether the mu opioid agonist DAMGO activates G proteins in rat brainstem nuclei that regulate REM sleep.
  • To understand the role of G protein activation in opioid-induced REM sleep inhibition.

Main Methods:

  • In vitro autoradiography was used to measure [35S]GTPgammaS binding.
  • DAMGO was applied to brainstem sections to assess G protein activation in specific nuclei.

Main Results:

  • DAMGO significantly increased G protein activation in multiple brainstem nuclei.
  • Key areas showing increased activation include the nucleus pontis oralis, nucleus pontis caudalis, laterodorsal tegmental nucleus, pedunculopontine tegmental nucleus, nucleus locus coeruleus, and dorsal raphe nucleus.

Conclusions:

  • DAMGO's stimulation of G protein binding in REM sleep-regulating nuclei supports its role in this process.
  • Opioid-induced REM sleep inhibition is suggested to involve the activation of G proteins.

Related Concept Videos